Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13 | $11 | $9 | $17 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $11 | $12 | $13 | $13 |
| Enterprise Value | $23 | $22 | $21 | $29 |
| Revenue | $19 | $19 | $19 | $18 |
| % Growth | -0.6% | 0.3% | 10.1% | – |
| Gross Profit | $5 | $5 | $5 | $5 |
| % Margin | 24.6% | 25.3% | 25.2% | 27.1% |
| EBITDA | $3 | $3 | $3 | $4 |
| % Margin | 16.6% | 16.5% | 17.6% | 20.1% |
| Net Income | $1 | $0 | $1 | $1 |
| % Margin | 2.8% | 2.6% | 3.5% | 5.5% |
| EPS Diluted | 0.92 | 0.85 | 0.57 | 0.83 |
| % Growth | 8.2% | 49.1% | -31.3% | – |
| Operating Cash Flow | $2 | $3 | $2 | $2 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $2 | $2 | $1 | $2 |